Comparison of Quality of Life of the Patients Three Months after Uniportal
and Multiportal Thoracoscopic Lobectomy.
10.3779/j.issn.1009-3419.2023.102.42
- Author:
Qi ZHANG
1
;
Wei DAI
2
;
Xing WEI
2
;
Run XIANG
2
;
Hang GU
2
;
Peihong HU
2
;
Mingxin LIU
2
;
Wei CHEN
1
;
Huaijun GONG
1
;
Yong LIANG
1
;
Shichao ZHANG
1
;
Weixing PENG
1
;
Qiuling SHI
2
;
Qiang LI
2
;
Nanbin YU
1
Author Information
1. Department of Thoracic Surgery, Zigong Third People's Hospital, Zigong 643020, China.
2. Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of
University of Electronic Science and Technology of China, Chengdu 610041, China.
- Publication Type:Journal Article
- Keywords:
Lung neoplasms;
Multiportal thoracoscopy;
Patient-reported outcomes;
Quality of life;
Uniportal thoracoscopy
- MeSH:
Male;
Female;
Humans;
Lung Neoplasms/surgery*;
Quality of Life;
Thoracic Surgery, Video-Assisted/adverse effects*;
Pneumonectomy/adverse effects*;
Postoperative Complications/surgery*;
Retrospective Studies
- From:
Chinese Journal of Lung Cancer
2023;26(11):843-850
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:The relationship between quality of life at three months after lung cancer surgery and different surgical approaches is remains unclear. This study aimed to compare the quality of life of patients three months after uniportal and multiportal thoracoscopic lobectomy.
METHODS:Data from patients who underwent lung surgery at the Department of Thoracic Surgery, Sichuan Cancer Hospital between April 2021 and October 2021 were collected. The European Organization for Research and Treatment of Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and Quality of Life Questionnaire-Lung Cancer 29 (EORTC QLQ-LC29) were used to collect quality of life data of the patients. Potential confounding factors in the baseline data were included in a multivariate regression model for adjustment, and the quality of life of the two groups three months postoperatively was compared with traditional clinical outcomes.
RESULTS:A total of 130 lung cancer patients were included, with 57 males (43.8%) and 73 females (56.2%), and an average age of (57.1±9.5) yr. In the baseline data of the two groups, there was a statistical difference in the number of chest drainage tubes placed (P<0.001). After adjustment with the regression model, at three months postoperatively, there were no significant differences in all symptoms and functional status scores between the two groups (all P>0.05). The multiportal group had longer surgery time (120.0 min vs 85.0 min, P=0.001), postoperative hospital stay (6.0 d vs 4.0 d, P=0.020), and a higher incidence of early ≥ grade 2 complications (39.0% vs 10.1%, P=0.011) compared to the uniportal group.
CONCLUSIONS:Patients undergoing uniportal and multiportal thoracoscopic lobectomy have similar quality of life at three months postoperatively. The uniportal group may have certain advantages in terms of traditional clinical outcome indicators such as operation time, postoperative hospital stay, and early postoperative complications.
